je.st
news
Tag: clinical
Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide,...
2013-01-25 02:36:38| Biotech - Topix.net
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials evaluating a single tablet regimen containing tenofovir alafenamide for the treatment of HIV-1 infection in treatment-nai 1 2ve adults.
Tags: program
phase
clinical
initiates
Gilead Initiates Phase 3 Clinical Program For Tenofovir Alafenamide, A Novel Low-Dose Prodrug For The Treatment Of HIV
2013-01-24 09:30:00| drugdiscoveryonline News Articles
Gilead Sciences, Inc. recently announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults
Tags: the
of
program
treatment
Portable Grant Data Logger Used In Demanding Clinical Studies
2013-01-24 06:00:00| Industrial Newsroom - All News for Today
SQ2010 Logger's Universal Inputs Save Researchers Time and Hassle CHESTERLAND OH - CAS DataLoggers has recently provided the portable data logging solution for a promising medical research application. The logger serves as an economical way to back up and support clinical studies into a variety of areas including pain relief. The aim of the study into pain relief was to investigate the effect of interferential current frequencies upon cutaneous blood flow in humans using Laser Doppler ...This story is related to the following:ServicesData Logging Recorders | Research & Development | Data Acquisition Software
Tags: data
studies
grant
portable
New Techniques For Streamlining The Inbound Supply Chain For The Clinical Lab Industry
2013-01-23 09:18:37| drugdiscoveryonline Downloads
In the highly competitive clinical laboratory field, a radical re-thinking of the inbound supply chain model can yield dramatic results for both profits and patients. ByUPS Healthcare
Tags: the
industry
supply
techniques
Esperion Announces Positive Topline Results from a Phase 2 Clinical...
2013-01-08 02:44:31| Biotech - Topix.net
Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced positive results of a recently completed Phase 2 clinical trial of ETC-1002 in patients with type 2 diabetes with LDL-C lowering of up to 43% compared to placebo.
Tags: results
positive
phase
clinical
Sites : [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58]